Abstract
Gynecomastia—the enlargement of male breast tissue in men—is a common finding, frequently observed in newborns, adolescents, and old men. Physiological gynecomastia, occurring in almost 25 % of cases, is benign and self-limited; on the other hand, several conditions and drugs may induce proliferation of male breast tissue. True gynecomastia is a common feature often related to estrogen excess and/or androgen deficiency as a consequence of different endocrine disorders. Biochemical evaluation should be performed once physiological or iatrogenic gynecomastia has been ruled out. Non-endocrine illnesses, including liver failure and chronic kidney disease, are another cause of gynecomastia which should be considered. Treating the underlying disease or discontinuing medications might resolve gynecomastia, although the psychosocial burden of this condition might require different and careful consideration.
Similar content being viewed by others
References
N. Cuhaci, S.B. Polat, B. Evranos, R. Ersoy, B. Cakir, Gynecomastia: clinical evaluation and management. Indian J Endocrinol Metab 18(2), 150–158 (2014). doi:10.4103/2230-8210.129104
R.E. Johnson, M.H. Murad, Gynecomastia: pathophysiology, evaluation, and management. Mayo Clin. Proc. 84(11), 1010–1015 (2009). doi:10.1016/S0025-6196(11)60671-X
R.E. Johnson, C.A. Kermott, M.H. Murad, Gynecomastia—evaluation and current treatment options. Ther. Clin. Risk Manag. 7, 145–148 (2011). doi:10.2147/TCRM.S10181
R. Mathur, G.D. Braunstein, Gynecomastia: pathomechanisms and treatment strategies. Horm. Res. 48(3), 95–102 (1997)
B. Ladizinski, K.C. Lee, F.N. Nutan, H.W. Higgins II, D.G. Federman, Gynecomastia: etiologies, clinical presentations, diagnosis, and management. South. Med. J. 107(1), 44–49 (2014). doi:10.1097/SMJ.0000000000000033
M. Kipling, J.E. Ralph, K. Callanan, Psychological impact of male breast disorders: literature review and survey results. Breast Care (Basel) 9(1), 29–33 (2014). doi:10.1159/000358751
H.S. Narula, H.E. Carlson, Gynaecomastia–pathophysiology, diagnosis and treatment. Nat Rev Endocrinol 10(11), 684–698 (2014). doi:10.1038/nrendo.2014.139
L. Rew, C. Young, T. Harrison, R. Caridi, A systematic review of literature on psychosocial aspects of gynecomastia in adolescents and young men. J. Adolesc. 43, 206–212 (2015). doi:10.1016/j.adolescence.2015.06.007
G.D. Braunstein, Clinical practice. Gynecomastia. N. Engl. J. Med. 357(12), 1229–1237 (2007). doi:10.1056/NEJMcp070677
E. Sloand, Pediatric and adolescent breast health. Lippincotts Prim. Care Pract. 2(2), 170–175 (1998)
G. Dickson, Gynecomastia. Am. Fam. Physician 85(7), 716–722 (2012)
G.D. Braunstein, Aromatase and gynecomastia. Endocr. Relat. Cancer 6(2), 315–324 (1999)
R.S. Swerdloff, J. Ng, Gynecomastia: etiology, diagnosis, and treatment, in Endotext, ed. by L.J. De Groot, P. Beck-Peccoz, G. Chrousos, K. Dungan, A. Grossman, J.M. Hershman, C. Koch, R. McLachlan, M. New, R. Rebar, F. Singer, A. Vinik, M.O. Weickert (MDText.com, Inc, South Dartmouth, MA, 2000)
N. Rokutanda, T. Iwasaki, H. Odawara, R. Nagaoka, W. Miyazaki, A. Takeshita, Y. Koibuchi, J. Horiguchi, N. Shimokawa, Y. Iino, Y. Morishita, N. Koibuchi, Augmentation of estrogen receptor-mediated transcription by steroid and xenobiotic receptor. Endocrine 33(3), 305–316 (2008). doi:10.1007/s12020-008-9091-9
S.A. Bembo, H.E. Carlson, Gynecomastia: its features, and when and how to treat it. Clevel. Clin. J. Med. 71(6), 511–517 (2004)
R.N. Morcos, T. Kizy, Gynecomastia: when is treatment indicated? J. Fam. Pract. 61(12), 719–725 (2012)
E. Nieschlag, Klinefelter syndrome: the commonest form of hypogonadism, but often overlooked or untreated. Dtsch. Arztebl. Int. 110(20), 347–353 (2013). doi:10.3238/arztebl.2013.0347
F. Lanfranco, A. Kamischke, M. Zitzmann, E. Nieschlag, Klinefelter’s syndrome. Lancet 364(9430), 273–283 (2004). doi:10.1016/S0140-6736(04)16678-6
L.A. Brinton, Breast cancer risk among patients with Klinefelter syndrome. Acta Paediatr. 100(6), 814–818 (2011). doi:10.1111/j.1651-2227.2010.02131.x
M. Galdiero, R. Pivonello, L.F. Grasso, A. Cozzolino, A. Colao, Growth hormone, prolactin, and sexuality. J. Endocrinol. Investig. 35(8), 782–794 (2012). doi:10.1007/BF03345805
M. Maggi, J. Buvat, G. Corona, A. Guay, L.O. Torres, Hormonal causes of male sexual dysfunctions and their management (hyperprolactinemia, thyroid disorders, GH disorders, and DHEA). J. Sex Med. 10(3), 661–677 (2013). doi:10.1111/j.1743-6109.2012.02735.x
A. Sansone, F. Romanelli, D. Gianfrilli, A. Lenzi, Endocrine evaluation of erectile dysfunction. Endocrine 46(3), 423–430 (2014). doi:10.1007/s12020-014-0254-6
M. Ferreira, M. Mesquita, M. Quaresma, S. Andre, Prolactin receptor expression in gynaecomastia and male breast carcinoma. Histopathology 53(1), 56–61 (2008). doi:10.1111/j.1365-2559.2008.03059.x
H.C. Mertani, T. Garcia-Caballero, A. Lambert, F. Gerard, C. Palayer, J.M. Boutin, B.K. Vonderhaar, M.J. Waters, P.E. Lobie, G. Morel, Cellular expression of growth hormone and prolactin receptors in human breast disorders. Int. J. Cancer 79(2), 202–211 (1998). doi:10.1002/(SICI)1097-0215(19980417)79:2<202:AID-IJC17>3.0.CO;2-B
R.C. Hovey, J.F. Trott, E. Ginsburg, A. Goldhar, M.M. Sasaki, S.J. Fountain, K. Sundararajan, B.K. Vonderhaar, Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland. Dev. Dyn. 222(2), 192–205 (2001). doi:10.1002/dvdy.1179
M.L. Bravo, M.P. Pinto, I. Gonzalez, B. Oliva, S. Kato, M.A. Cuello, C.A. Lange, G.I. Owen, Progesterone regulation of tissue factor depends on MEK1/2 activation and requires the proline-rich site on progesterone receptor. Endocrine 48(1), 309–320 (2015). doi:10.1007/s12020-014-0288-9
F. Chentli, I. Bekkaye, S. Azzoug, Feminizing adrenocortical tumors: literature review. Indian J. Endocrinol. Metab. 19(3), 332–339 (2015). doi:10.4103/2230-8210.152764
S. Kayemba-Kays, G. Fromont-Hankard, G. Lettelier, S. Gabriel, G. Levard, Leydig cell tumour revealed by bilateral gynecomastia in a 15-year-old adolescent: a patient report. J. Pediatr. Endocrinol. Metab. 23(11), 1195–1199 (2010)
H. Djaladat, C. Nichols, S. Daneshmand, Androgen-producing testicular germ cell tumors. J. Clin. Oncol. 29(21), e634–e635 (2011). doi:10.1200/JCO.2011.35.1965
N. Kolitsas, S. Tsambalas, F. Dimitriadis, D. Baltogiannis, E. Vlachopoulou, S. Vappa, D. Giannakis, P. Tsounapi, A. Takenaka, N. Sofikitis, Gynecomastia as a first clinical sign of nonseminomatous germ cell tumor. Urol. Int. 87(2), 248–250 (2011). doi:10.1159/000328387
S. Kaptanis, L. Parvanta, L. Beltran, Testicular seminoma presenting as unilateral gynecomastia. Breast J. 20(4), 424–426 (2014). doi:10.1111/tbj.12287
S.M. Stevenson, W.T. Lowrance, Epidemiology and diagnosis of testis cancer. Urol. Clin. N. Am. 42(3), 269–275 (2015). doi:10.1016/j.ucl.2015.04.001
B. Hayes-Lattin, C.R. Nichols, Testicular cancer: a prototypic tumor of young adults. Semin. Oncol. 36(5), 432–438 (2009). doi:10.1053/j.seminoncol.2009.07.006
Y. Huang, J. Song, M. Xu, Q. Zan, Primary Leydig cell tumour of epididymis: a rare case report with review of literature. Andrologia 45(6), 430–433 (2013). doi:10.1111/and.12049
F. Deepinder, G.D. Braunstein, Drug-induced gynecomastia: an evidence-based review. Expert Opin. Drug Saf. 11(5), 779–795 (2012). doi:10.1517/14740338.2012.712109
M.G. Forest, A. Lecoq, J.M. Saez, Kinetics of human chorionic gonadotropin-induced steroidogenic response of the human testis. II. Plasma 17 α-hydroxyprogesterone, δ4-androstenedione, estrone, and 17 β-estradiol: evidence for the action of human chorionic gonadotropin on intermediate enzymes implicated in steroid biosynthesis. J. Clin. Endocrinol. Metab. 49(2), 284–291 (1979). doi:10.1210/jcem-49-2-284
S.A. Berson, S.S. Schreiber, Gynecomastia and hyperthyroidism. J. Clin. Endocrinol. Metab. 13(9), 1126–1128 (1953). doi:10.1210/jcem-13-9-1126
K.L. Becker, J.L. Winnacker, M.J. Matthews, G.A. Higgins Jr, Gynecomastia and hyperthyroidism. An endocrine and histological investigation. J. Clin. Endocrinol. Metab. 28(2), 277–285 (1968). doi:10.1210/jcem-28-2-277
H.K. Ho, K.C. Loh, Hyperthyroidism with gynaecomastia as the initial complaint: a case report. Ann. Acad. Med. Singapore 27(4), 594–596 (1998)
W.B. Chan, V.T. Yeung, C.C. Chow, W.Y. So, C.S. Cockram, Gynaecomastia as a presenting feature of thyrotoxicosis. Postgrad. Med. J. 75(882), 229–231 (1999)
E.A. Jannini, S. Ulisse, M. D’Armiento, Thyroid hormone and male gonadal function. Endocr. Rev. 16(4), 443–459 (1995). doi:10.1210/edrv-16-4-443
A.W. Meikle, The interrelationships between thyroid dysfunction and hypogonadism in men and boys. Thyroid 14(Suppl 1), S17–25 (2004). doi:10.1089/105072504323024552
G.E. Krassas, K. Poppe, D. Glinoer, Thyroid function and human reproductive health. Endocr. Rev. 31(5), 702–755 (2010). doi:10.1210/er.2009-0041
M. Caprio, E. Fabbrini, A.M. Isidori, A. Aversa, A. Fabbri, Leptin in reproduction. Trends Endocrinol. Metab. 12(2), 65–72 (2001)
M.J. Vazquez, A. Romero-Ruiz, M. Tena-Sempere, Roles of leptin in reproduction, pregnancy and polycystic ovary syndrome: consensus knowledge and recent developments. Metabolism 64(1), 79–91 (2015). doi:10.1016/j.metabol.2014.10.013
A. Sansone, F. Romanelli, E.A. Jannini, A. Lenzi, Hormonal correlations of premature ejaculation. Endocrine 49(2), 333–338 (2015). doi:10.1007/s12020-014-0520-7
I.S. Farooqi, S. O’Rahilly, 20 Years of leptin: human disorders of leptin action. J. Endocrinol. 223(1), T63–T70 (2014). doi:10.1530/JOE-14-0480
B. Dundar, N. Dundar, T. Erci, E. Bober, A. Buyukgebiz, Leptin levels in boys with pubertal gynecomastia. J. Pediatr. Endocrinol. Metab. 18(10), 929–934 (2005)
E. Eren, T. Edgunlu, H.A. Korkmaz, E.D. Cakir, K. Demir, E.S. Cetin, S.K. Celik, Genetic variants of estrogen beta and leptin receptors may cause gynecomastia in adolescent. Gene 541(2), 101–106 (2014). doi:10.1016/j.gene.2014.03.013
S. Catalano, S. Marsico, C. Giordano, L. Mauro, P. Rizza, M.L. Panno, S. Ando, Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line. J. Biol. Chem. 278(31), 28668–28676 (2003). doi:10.1074/jbc.M301695200
S. Catalano, L. Mauro, S. Marsico, C. Giordano, P. Rizza, V. Rago, D. Montanaro, M. Maggiolini, M.L. Panno, S. Ando, Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells. J. Biol. Chem. 279(19), 19908–19915 (2004). doi:10.1074/jbc.M313191200
M.N. Dieudonne, A. Sammari, E. Dos Santos, M.C. Leneveu, Y. Giudicelli, R. Pecquery, Sex steroids and leptin regulate 11 β-hydroxysteroid dehydrogenase I and P450 aromatase expressions in human preadipocytes: sex specificities. J. Steroid Biochem. Mol. Biol. 99(4–5), 189–196 (2006). doi:10.1016/j.jsbmb.2006.01.007
B. Lapauw, G. T’Sjoen, A. Mahmoud, J.M. Kaufman, J.B. Ruige, Short-term aromatase inhibition: effects on glucose metabolism and serum leptin levels in young and elderly men. Eur. J. Endocrinol. 160(3), 397–402 (2009). doi:10.1530/EJE-08-0881
C.N. Habib, A.M. Al-Abd, M.F. Tolba, A.E. Khalifa, A. Khedr, H.A. Mosli, A.B. Abdel-Naim, Leptin influences estrogen metabolism and accelerates prostate cell proliferation. Life Sci. 121(C), 10–15 (2015). doi:10.1016/j.lfs.2014.11.007
S.T. Ng, J. Zhou, O.O. Adesanya, J. Wang, D. LeRoith, C.A. Bondy, Growth hormone treatment induces mammary gland hyperplasia in aging primates. Nat. Med. 3(10), 1141–1144 (1997)
M.G. Mieritz, K. Sorensen, L. Aksglaede, A. Mouritsen, C.P. Hagen, L. Hilsted, A.M. Andersson, A. Juul, Elevated serum IGF-I, but unaltered sex steroid levels, in healthy boys with pubertal gynaecomastia. Clin. Endocrinol. (Oxf.) 80(5), 691–698 (2014). doi:10.1111/cen.12323
L.J. De Groot, P. Beck-Peccoz, G. Chrousos, K. Dungan, A. Grossman, J.M. Hershman, C. Koch, R. McLachlan, M. New, R. Rebar, F. Singer, A. Vinik, M.O. Weickert, R.S. Swerdloff, J. Ng, Gynecomastia: etiology, diagnosis, and treatment, vol. 53 (MDText.com, Inc, South Dartmouth, MA, 2000)
M.G. Mieritz, L.L. Raket, C.P. Hagen, J.E. Nielsen, M.L. Talman, J.H. Petersen, S.H. Sommer, K.M. Main, N. Jorgensen, A. Juul, A longitudinal study of growth, sex steroids, and IGF-1 in boys with physiological gynecomastia. J. Clin. Endocrinol. Metab. 100(10), 3752–3759 (2015). doi:10.1210/jc.2015-2836
F.M. Souza, P.F. Collett-Solberg, Adverse effects of growth hormone replacement therapy in children. Arq. Bras. Endocrinol. Metab. 55(8), 559–565 (2011)
H. Liu, D.M. Bravata, I. Olkin, S. Nayak, B. Roberts, A.M. Garber, A.R. Hoffman, Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann. Intern. Med. 146(2), 104–115 (2007)
S.V. Acharya, R.A. Gopal, T.R. Bandgar, P.S. Menon, N.S. Shah, Prepubertal gynecomastia a rare complication of growth hormone therapy. Indian J. Pediatr. 77(4), 443–444 (2010). doi:10.1007/s12098-010-0012-6
D.B. Young, 6′6″ United States marine seeks treatment for gynecomastia only to learn it is all in his head. Mil. Med. 180(12), e1290–e1292 (2015). doi:10.7205/MILMED-D-15-00248
M. Derkacz, I. Chmiel-Perzynska, A. Nowakowski, Gynecomastia—a difficult diagnostic problem. Endokrynol. Pol. 62(2), 190–202 (2011)
M. Sinclair, M. Grossmann, P.J. Gow, P.W. Angus, Testosterone in men with advanced liver disease: abnormalities and implications. J. Gastroenterol. Hepatol. 30(2), 244–251 (2015). doi:10.1111/jgh.12695
P. Iglesias, J.J. Carrero, J.J. Diez, Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options. J. Nephrol. 25(1), 31–42 (2012). doi:10.5301/JN.2011.8481
W. Krause, Drug-inducing gynaecomastia—a critical review. Andrologia 44(Suppl 1), 621–626 (2012). doi:10.1111/j.1439-0272.2011.01240.x
J.D. Bowman, H. Kim, J.J. Bustamante, Drug-induced gynecomastia. Pharmacotherapy 32(12), 1123–1140 (2012). doi:10.1002/phar.1138
L. Di Luigi, F. Romanelli, A. Lenzi, Androgenic–anabolic steroids abuse in males. J. Endocrinol. Investig. 28(3 Suppl), 81–84 (2005)
L. Di Luigi, F. Romanelli, P. Sgro, A. Lenzi, Andrological aspects of physical exercise and sport medicine. Endocrine 42(2), 278–284 (2012). doi:10.1007/s12020-012-9655-6
E. Nieschlag, E. Vorona, Mechanisms in endocrinology: medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions. Eur. J. Endocrinol. 173(2), R47–R58 (2015). doi:10.1530/EJE-15-0080
S. Basaria, Androgen abuse in athletes: detection and consequences. J. Clin. Endocrinol. Metab. 95(4), 1533–1543 (2010). doi:10.1210/jc.2009-1579
A. Momaya, M. Fawal, R. Estes, Performance-enhancing substances in sports: a review of the literature. Sports Med. 45(4), 517–531 (2015). doi:10.1007/s40279-015-0308-9
V. Birzniece, Doping in sport: effects, harm and misconceptions. Intern. Med. J. 45(3), 239–248 (2015). doi:10.1111/imj.12629
A. Eckman, A. Dobs, Drug-induced gynecomastia. Expert Opin. Drug Saf. 7(6), 691–702 (2008). doi:10.1517/14740330802442382
J. Martinez, J.E. Lewi, An unusual case of gynecomastia associated with soy product consumption. Endocr. Pract. 14(4), 415–418 (2008). doi:10.4158/EP.14.4.415
M. Messina, Soybean isoflavone exposure does not have feminizing effects on men: a critical examination of the clinical evidence. Fertil. Steril. 93(7), 2095–2104 (2010). doi:10.1016/j.fertnstert.2010.03.002
A. Vivacqua, A.G. Recchia, G. Fasanella, S. Gabriele, A. Carpino, V. Rago, M.L. Di Gioia, A. Leggio, D. Bonofiglio, A. Liguori, M. Maggiolini, The food contaminants bisphenol A and 4-nonylphenol act as agonists for estrogen receptor alpha in MCF7 breast cancer cells. Endocrine 22(3), 275–284 (2003). doi:10.1385/ENDO:22:3:275
D.V. Henley, N. Lipson, K.S. Korach, C.A. Bloch, Prepubertal gynecomastia linked to lavender and tea tree oils. N. Engl. J. Med. 356(5), 479–485 (2007). doi:10.1056/NEJMoa064725
L.R. Chadwick, D. Nikolic, J.E. Burdette, C.R. Overk, J.L. Bolton, R.B. van Breemen, R. Frohlich, H.H. Fong, N.R. Farnsworth, G.F. Pauli, Estrogens and congeners from spent hops (Humulus lupulus). J. Nat. Prod. 67(12), 2024–2032 (2004). doi:10.1021/np049783i
R.D. Goldman, Drug-induced gynecomastia in children and adolescents. Can. Fam. Phys. 56(4), 344–345 (2010)
M.A. Sauer, S.M. Rifka, R.L. Hawks, G.B. Cutler Jr, D.L. Loriaux, Marijuana: interaction with the estrogen receptor. J. Pharmacol. Exp. Ther. 224(2), 404–407 (1983)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Sansone, A., Romanelli, F., Sansone, M. et al. Gynecomastia and hormones. Endocrine 55, 37–44 (2017). https://doi.org/10.1007/s12020-016-0975-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-016-0975-9